Impact of Hemoglobin Levels and Their Dynamic Changes on the Risk of Atrial Fibrillation: A Nationwide Population-Based Study.
Woo-Hyun LimEue-Keun ChoiKyung-Do HanSo-Ryoung LeeMyung-Jin ChaSeil OhPublished in: Scientific reports (2020)
Anemia is a risk factor for cardiovascular disease, but its impact on new-onset atrial fibrillation (AF) is unclear. In this study, we investigated the effect of hemoglobin (Hb) levels and their changes on the risk of AF development in the general population of Korea. We retrospectively analyzed a cohort from the Korean National Health Insurance Service database and identified 9,686,314 subjects (49.8% male) without a history of AF, aged ≥40 years, and with Hb levels available for both first (2009-2010) and second (2011-2012) health checkups. These subjects were followed up until 2017 to determine AF development. The presence of anemia (Hb level <13 g/dL in men and <12 g/dL in women) was a significant risk factor for AF development. However, Hb levels showed a U-shaped association with incident AF after adjustment for cardiovascular risk factors. AF incidence was lowest at Hb levels of 14-14.9 g/dL in men and 12-12.9 g/dL in women. Among individuals with Hb levels within normal ranges (13-15.9 g/dL in men and 12-14.9 g/dL in women), both decrease and increase in Hb levels at the second measurement outside the normal ranges showed an elevation of AF risk by 11% and 21% for men and 3% and 36% for women, respectively, compared with those who maintained normal Hb levels. In conclusion, low or high Hb levels are associated with an increased risk of incident AF. This study suggests that maintaining Hb levels within the normal ranges confers a low risk of AF development.
Keyphrases
- atrial fibrillation
- cardiovascular disease
- health insurance
- healthcare
- polycystic ovary syndrome
- left atrial
- catheter ablation
- heart failure
- pregnant women
- chronic kidney disease
- left atrial appendage
- public health
- middle aged
- mental health
- acute coronary syndrome
- coronary artery disease
- risk assessment
- percutaneous coronary intervention
- insulin resistance
- left ventricular
- mass spectrometry
- social media
- venous thromboembolism
- quality improvement
- human health
- pregnancy outcomes
- cardiovascular events
- adverse drug